Kevin Pojasek, Ervaxx CEO, said the collaboration with the Cardiff University research group “shows early but enormous potential for the treatment of cancers.”
New Partnership Could Lead To ‘An Almost Instant Off-The-Shelf’ ‘One-Size-Fits-All’ Cancer Treatment
